2025 Japan Biobanking Market Revenue Opportunities Report
Description
The 2025 Japan Biobanking Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Biobanking Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Japan biobanking market include Thermo Fisher Scientific Inc., PHC Holdings Corporation, Becton Dickinson & Co., and Merck KGaA. Thermo Fisher Scientific is a significant global player providing advanced biobanking equipment and consumables, supporting the growth of personalized medicine and genomic research in Japan. PHC Holdings Corporation, a Japan-based firm, specializes in cryopreservation and biological storage solutions critical for maintaining sample integrity. Becton Dickinson & Co. focuses on biobanking consumables and systems critical to clinical trials and research. Merck KGaA is involved with biobank infrastructure and technologies supporting biopharma and biotech research collaboration.
These companies leverage Japan's robust healthcare infrastructure, supported by initiatives like the National Center Biobank Network and BioBank Japan, which emphasize quality control, advanced data management, and integration with precision medicine efforts. Japan's biobanking market is growing rapidly due to increasing demands in cancer, cardiovascular, and chronic disease research, driven by an aging population and government support for regenerative medicine and genomics. These leaders continuously innovate biobanking equipment, consumables, and digital systems (LIMS), promoting advances in personalized medicine and fostering collaborations between academic, pharmaceutical, and biotech sectors.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Biobanking Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Japan biobanking market include Thermo Fisher Scientific Inc., PHC Holdings Corporation, Becton Dickinson & Co., and Merck KGaA. Thermo Fisher Scientific is a significant global player providing advanced biobanking equipment and consumables, supporting the growth of personalized medicine and genomic research in Japan. PHC Holdings Corporation, a Japan-based firm, specializes in cryopreservation and biological storage solutions critical for maintaining sample integrity. Becton Dickinson & Co. focuses on biobanking consumables and systems critical to clinical trials and research. Merck KGaA is involved with biobank infrastructure and technologies supporting biopharma and biotech research collaboration.
These companies leverage Japan's robust healthcare infrastructure, supported by initiatives like the National Center Biobank Network and BioBank Japan, which emphasize quality control, advanced data management, and integration with precision medicine efforts. Japan's biobanking market is growing rapidly due to increasing demands in cancer, cardiovascular, and chronic disease research, driven by an aging population and government support for regenerative medicine and genomics. These leaders continuously innovate biobanking equipment, consumables, and digital systems (LIMS), promoting advances in personalized medicine and fostering collaborations between academic, pharmaceutical, and biotech sectors.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
